Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities

Paul A Armitage1, Andrew J Farrall, Trevor K Carpenter

  • 1Clinical Neurosciences, School of Molecular and Clinical Medicine, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU, Scotland, UK. paul.armitage@ed.ac.uk

Insights

Dynamic contrast-enhanced MRI (DCE-MRI) shows subtle blood-brain barrier (BBB) changes in mild stroke. Preliminary results indicate that scanner noise and tissue properties introduce uncertainty, complicating BBB abnormality assessment.

Area of Science:

  • Neurology
  • Medical Imaging
  • Biophysics

Background:

  • Subtle blood-brain barrier (BBB) dysfunction is implicated in neurological disorders.
  • Dynamic contrast-enhanced MRI (DCE-MRI) is explored for assessing BBB abnormalities.
  • Previous DCE-MRI studies showed smaller signal changes in subtle BBB changes compared to tumors or MS.

Purpose of the Study:

  • To present preliminary DCE-MRI results in mild stroke patients.
  • To estimate signal enhancement profiles in different tissues and white matter abnormalities.
  • To investigate factors affecting signal enhancement and their implications for BBB assessment.

Main Methods:

  • DCE-MRI was used in mild stroke patients categorized by white matter abnormalities.
  • Signal enhancement profiles were analyzed across tissue types and abnormality degrees.
  • The influence of scanner noise, drift, and tissue properties on signal enhancement was investigated.

Main Results:

  • No significant differences in average signal enhancement or contrast agent concentration were found between patient groups.
  • A trend towards greater signal enhancement was observed with increased white matter abnormality.
  • Factors like scanner noise and tissue properties introduce uncertainty comparable to expected effect sizes.

Conclusions:

  • Current DCE-MRI findings in mild stroke are confounded by technical factors, making BBB abnormality assessment challenging.
  • Further research is needed for reliable quantification of BBB function and contrast agent concentration in human tissues.
  • Future studies must incorporate appropriate control groups to mitigate confounding influences on DCE-MRI signal enhancement.